The main developments reported during the morning session involved multiple stocks: HEALIOS's first shipment of its culture supernatant product, SanBio's clinical administration, Sysmex's emergence as a major shareholder, Digital Plus's increase in gross transaction value, Monogatari Corporation's leakage of member information, and Ichibanya's first-half earnings trend.
HEALIOS shipped its first order of its culture supernatant product, worth ¥140 million, to Korea-based JE NECEL, an Alfresa Holdings group company, and plans to recognize the sales in Q4. This was the first commercial shipment of a product based on cell culture supernatant. HEALIOS is adjusting shipment volumes and timing toward continued orders and is also working to build relationships with other business partners.
SanBio announced that administration of its “Acugo intracerebral implantation product” to the first post-marketing patient was performed at Hokkaido University Hospital. The patient's progress after administration is scheduled to be carefully monitored by the medical institution.
BlackRock Japan emerged as a major shareholder of Sysmex, with a 5.03% ownership stake, according to a Large Shareholding Report received on 5 October. The stated purpose of the holding is pure investment.
Digital Plus's gross transaction value for the fiscal year ending September 2026 was approximately ¥32.0 billion, 2.5 times the previous fiscal year, while Q4 gross transaction value rose 19% quarter on quarter to ¥11.6 billion.
Monogatari Corporation announced that a third party had gained unauthorized access to the member management system for the official Yakiniku King app, resulting in the leakage of member information. Approximately 10,788,963 records were exposed, including member numbers, names, email addresses and telephone numbers.
Ichibanya's consolidated operating profit for the first half of the fiscal year ending February 2027 was ¥2.09 billion, down 17.2% year on year, reflecting higher food material prices and logistics costs. The full-year forecast was left unchanged at ¥5.00 billion.